, Tracking Stock Market Picks
Enter Symbol:
Intec Pharma Ltd. (NTEC) [hlAlert]

Mkt Outperform
up 773.84 %

Neose Technologies, Inc. (NTEC) rated Mkt Outperform with price target $3 by Rodman & Renshaw

Posted on: Thursday,  Feb 7, 2008  10:25 AM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Outperform Intec Pharma Ltd. (NASDAQ: NTEC) on 02/07/2008, when the stock price was $0.65.
Since then, Intec Pharma Ltd. has gained 773.85% as of 09/16/2015's recent price of $5.68.
If you would have followed this Rodman & Renshaw's recommendation on NTEC, you would have gained 773.84% of your investment in 2778 days.

Neose Technologies Inc. is a leading developer of proprietary technologies for the synthesis and manufacture of complex carbohydrates. Complex carbohydrates are critically important molecules in biological processes. On cell surfaces, they regulate communications with other cells, hormones, nutrients, and growth and death factors. Traditionally, complex carbohydrates have been difficult and expensive to produce in commercial quantities.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/7/2008 10:25 AM Buy
0.65 3.00
as of 8/27/2015
1 Week down  -5.17 %
1 Month up  51,536.36 %
3 Months up  51,536.36 %
1 YTD up  1,675.00 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy